Insider Trading & Ownership - Hoberman Kenneth

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hoberman Kenneth
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-12
Purchase
2022-05-16
08:33 am
Nuvectis Pharma Inc.NVCTHoberman Kenneth
Director
6,000$17.4$104,40055,140
(Direct)
View
2020-03-09
Sale
2020-03-13
9:31 pm
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
26,191$4.9716$130,211771,764
(Direct)
View
2020-02-25
Sale
2020-02-28
9:31 pm
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
11,547$6.42$74,132797,955
(Direct)
View
2020-01-22
Sale
2020-01-24
9:31 pm
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
22,139$7.02$155,416601,085
(Direct)
View
2020-01-08
Sale
2020-01-10
9:16 pm
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
13,228$10.37$137,174623,224
(Direct)
View
2019-12-23
Sale
2020-01-03
5:19 pm
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
46,312$10.84$501,959636,452
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-19
Option Award
2024-06-20
6:05 pm
N/A
N/A
TG THERAPEUTICS INC.TGTXHoberman Kenneth
Director
22,250$0264,935
(Direct)
View
2024-06-13
Option Award
2024-06-13
4:22 pm
N/A
N/A
Nuvectis Pharma Inc.NVCTHoberman Kenneth
Director
30,000$0103,140
(Direct)
View
2023-09-28
Option Award
2023-09-29
5:01 pm
N/A
N/A
TG THERAPEUTICS INC.TGTXHoberman Kenneth
Director
20,000$0242,685
(Direct)
View
2023-06-16
Option Award
2023-06-20
08:15 am
N/A
N/A
Nuvectis Pharma Inc.NVCTHoberman Kenneth
Director
18,000$073,140
(Direct)
View
2022-07-20
Option Award
2022-07-22
4:31 pm
N/A
N/A
TG THERAPEUTICS INC.TGTXHoberman Kenneth
Director
43,732$0222,685
(Direct)
View
2022-04-01
Option Award
2022-04-05
4:47 pm
2023-04-01
2032-04-01
Nuvectis Pharma Inc.NVCTHoberman Kenneth
Director
15,000$015,000
(Direct)
View

Ownership
2022-02-08
08:29 am
N/A
N/A
Nuvectis Pharma Inc.NVCTHoberman Kenneth
Director
0$078,390
(Direct)
View
2021-06-18
Option Award
2021-06-22
6:25 pm
N/A
N/A
TG THERAPEUTICS INC.TGTXHoberman Kenneth
Director
20,000$0178,953
(Direct)
View
2020-06-22
Option Award
2020-06-24
7:50 pm
N/A
N/A
TG THERAPEUTICS INC.TGTXHoberman Kenneth
Director
15,000$0158,953
(Direct)
View
2020-06-10
Equity Swap
2020-06-10
11:18 am
N/A
N/A
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
1,374,352$00
(Direct)
View
2020-06-10
Disposition
2020-06-10
11:18 am
N/A
2026-01-07
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
69,058$00
(Direct)
View
2020-06-10
Option Award
2020-06-10
11:18 am
N/A
N/A
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
600,000$00
(Direct)
View
2020-02-10
Option Award
2020-02-14
9:29 pm
N/A
N/A
STEMLINE THERAPEUTICS INCSTMLHoberman Kenneth
Chief Operating Officer
208,417$0809,502
(Direct)
View